terazosin
NDC 68788-8171, terazosin, capsule, from Preferred Pharmaceuticals Inc..
- Product NDC
- 68788-8171
- Status
- Listed
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075614
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68788-8171-3 | 68788817103 | 30 CAPSULE in 1 BOTTLE (68788-8171-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a78f74ce-1c53-41ea-878e-13674db10a67
Use it
Look up 68788-8171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68788-8171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.